Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increase in prevalence of respiratory diseases
3.2.1.2 Rise in awareness levels and demand for over-the-counter (OTC) products
3.2.1.3 Surging geriatric population
3.2.2 Industry pitfalls & challenges
3.2.2.1 Side effects associated with cough medications
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pipeline analysis
3.6 Porter's analysis
3.7 PESTEL analysis
3.8 Future market trends
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Medication Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Antihistamines
5.3 Antibiotics
5.4 Bronchodilators
5.5 Decongestants
5.6 Expectorants
Chapter 6 Market Estimates and Forecast, By Dosage Form, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Oral syrups
6.3 Tablets/Pills
6.4 Nasal drop
6.5 Lozenges
Chapter 7 Market Estimates and Forecast, By Age Group, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Adult
7.3 Pediatric
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Retail pharmacy
8.3 Hospital pharmacy
8.4 Online pharmacy
8.5 Other distribution channels
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 AstraZeneca plc
10.2 Bayer AG
10.3 GSK plc
10.4 Johnson & Johnson
10.5 Novartis AG
10.6 Pfizer Inc.
10.7 Prestige Consumer Healthcare
10.8 Procter & Gamble
10.9 Reckitt Benckiser Group plc
10.10 Sun Pharmaceutical Industries Ltd
